Loss to Follow-up Among Patients With Neovascular Age-Related Macular Degeneration Who Received Intravitreal Anti-Vascular Endothelial Growth Factor Injections.

ABSTRACT:

Importance

Loss to follow-up (LTFU) after anti-vascular endothelial growth factor (anti-VEGF) injections increases the risk of vision loss among patients with neovascular age-related macular degeneration (nAMD).

Objective

To report rates of LTFU among patients with nAMD after anti-VEGF injections and to identify risk factors associated with LTFU in this population.

Design, setting, and participants

This retrospective cohort study of data from 9007 patients who received anti-VEGF injections for treatment of nAMD was performed at an urban, private retina practice with multiple locations from April 1, 2012, to January 12, 2016.

Main outcomes and measures

Rates of LTFU after anti-VEGF injections. Loss to follow-up was defined as receipt of 1 or more injections with

SUBMITTER: Obeid A 

PROVIDER: S-EPMC6583857 | biostudies-literature | 2018 Nov

REPOSITORIES: biostudies-literature